BiomX (PHGE) Tax Provisions (2018 - 2025)
BiomX (PHGE) posted Tax Provisions of -$7.6 million for Q4 2025, down 253633.33% sequentially from $3000.0 in Q3 2025, and down 103.91% YoY from $194.3 million in Q4 2024.
BiomX (PHGE) Tax Provisions (2018 - 2025) Analysis & Trends
BiomX has reported Tax Provisions for 7 years, with the latest figure at -$7.6 million in Q4 2025.
- Quarterly Tax Provisions fell 103.91% year-over-year to -$7.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$7.6 million (down 104.08% YoY) and the FY2025 annual result came in at -$7.6 million, down 104.3% from the prior year.
- Tax Provisions slipped to -$7.6 million in Q4 2025 per PHGE's latest filing, from $3000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $385000.0 in Q4 2022 and troughed at -$7.6 million in Q4 2025.
- A 5-year average of -$601333.3 and a median of $5500.0 in 2023 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2022 and 2024: Tax Provisions soared 654.9% in 2022, then sank 373100.0% in 2024.
- Over 5 years, Tax Provisions stood at $51000.0 in 2021, then jumped by 654.9% to $385000.0 in 2022, then tumbled by 99.74% to $1000.0 in 2023, then tumbled by 373100.0% to -$3.7 million in 2024, then sank by 103.91% to -$7.6 million in 2025.
- According to Business Quant data, Tax Provisions over the past three periods registered -$7.6 million, $3000.0, and $2000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.31 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.90 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -90.33 Mn |
| 10 | BiomX | 361,408.40 | -806,591.60 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.61 Mn |
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | -3.73 Mn |
| Jun 30, 2024 | 5,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 8,000.00 |
| Jun 30, 2023 | 8,000.00 |
| Mar 31, 2023 | 6,000.00 |
| Dec 31, 2022 | 385,000.00 |
| Sep 30, 2022 | 8,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Dec 31, 2021 | 51,000.00 |
| Sep 30, 2021 | 10,000.00 |
| Jun 30, 2021 | 3,000.00 |
| Mar 31, 2021 | 3,000.00 |
| Sep 30, 2019 | 47,776.00 |
| Mar 31, 2019 | 77,468.00 |